Cheng, J. ., Holland-Letz, T. ., Wallwiener, M. ., Surowy, H. ., Cuk, K. ., Schott, S. ., … Burwinkel, B. . (2018). Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-018-4666-5 (Original work published 2018)

Schneeweiss, A. ., Park-Simon, T. ., Albanell, J. ., Lassen, U. ., Cortés, J. ., , … Cervantes, A. . (2018). Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Investigational New Drugs. https://doi.org/10.1007/s10637-018-0562-4 (Original work published 2018)